Tela Bio Inc (TELA) Institutional Buying & Selling Tracker (Q2 2026)

TELA ranks #6440 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

45 institutions disclose a position in TELA, but none treat it as a major bet — even Essex Woodlands Management, Inc., its most concentrated holder, allocates just 2.3% of its own portfolio to it.

Ducere Wealth Management LLC has added to its TELA position for two straight quarters, increasing it by $14.7K to reach $38.3K today.

UBS Group AG has trimmed its TELA position for two straight quarters, cutting it by $1.7M while still holding $25.1K.

TELA is down 5.9% today, and institutions have been net sellers of $1.4M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

TELA reported a net loss of $41.2M over the trailing twelve months.

• Not yet profitable — net loss of $41.2M over the trailing twelve months
• Revenue grew 6.1% year over year
• Net income declined year over year, from -$40.8M to -$41.2M
• Operating cash flow was negative, using $28.2M in cash
• Current ratio of 4.20x — enough short-term assets to cover short-term liabilities
• Liabilities run 11.90x equity — a highly leveraged balance sheet worth noting